Cargando…

Evaluation of therapeutic efficacy of (211)At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer

INTRODUCTION: Antibodies labeled with alpha-emitter astatine-211 have previously shown effective in intraperitoneal (i.p.) treatments of ovarian cancer. In the present work we explore the use of investigational farletuzumab, aimed at the folate receptor alpha. The aim was to evaluate the biodistribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palm, Stig, Bäck, Tom, Aneheim, Emma, Hallqvist, Andreas, Hultborn, Ragnar, Jacobsson, Lars, Jensen, Holger, Lindegren, Sture, Albertsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522120/ https://www.ncbi.nlm.nih.gov/pubmed/32987283 http://dx.doi.org/10.1016/j.tranon.2020.100873

Ejemplares similares

Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
por: Lindegren, Sture, et al.
Publicado: (2020)

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with (211)At Intraperitoneal Radioimmunotherapy
por: Leidermark, Erik, et al.
Publicado: (2023)

Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
por: Gustafsson-Lutz, Anna, et al.
Publicado: (2017)

Astatine-211 based radionuclide therapy: Current clinical trial landscape
por: Albertsson, Per, et al.
Publicado: (2023)

Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
por: Timperanza, Chiara, et al.
Publicado: (2023)

Automated astatination of biomolecules – a stepping stone towards multicenter clinical trials
por: Aneheim, Emma, et al.
Publicado: (2015)

Towards elucidating the radiochemistry of astatine – Behavior in chloroform
por: Aneheim, Emma, et al.
Publicado: (2019)

Repeated Intraperitoneal α-Radioimmunotherapy of Ovarian Cancer in Mice
por: Elgqvist, Jörgen, et al.
Publicado: (2010)

Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
por: Bäck, Tom A., et al.
Publicado: (2020)

Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200
por: Lindegren, Sture, et al.
Publicado: (2015)

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with (211)At-mAb
por: Eriksson, Sophie E, et al.
Publicado: (2013)

Covalent core-radiolabeling of polymeric micelles with (125)I/(211)At for theranostic radiotherapy
por: Sporer, Emanuel, et al.
Publicado: (2022)

Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio‐Crosslinking
por: Denk, Christoph, et al.
Publicado: (2019)

Profile of farletuzumab and its potential in the treatment of solid tumors
por: Sato, Seiya, et al.
Publicado: (2016)

Intraperitoneal Alpha-Radioimmunotherapy of Advanced Ovarian Cancer in Nude Mice Using Different High Specific Activities
por: Elgqvist, Jorgen, et al.
Publicado: (2010)

Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer
por: Farrell, Colm, et al.
Publicado: (2012)

Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer(,,)
por: Kim, Kenneth H., et al.
Publicado: (2015)

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
por: Sasaki, Yasutsuna, et al.
Publicado: (2014)

Stabilization of an (211)At-Labeled Antibody with Sodium Ascorbate
por: Manabe, Shino, et al.
Publicado: (2021)

Dark-field microscopy enhances visibility of CD31 endothelial staining
por: Jennische, Eva, et al.
Publicado: (2020)

Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
por: Huang, Xiuyu, et al.
Publicado: (2022)

Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain
por: Dai, Jinxiang, et al.
Publicado: (2022)

17AAG-induced internalisation of HER2-specific Affibody molecules
por: Göstring, Lovisa, et al.
Publicado: (2016)

Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
por: Kato, Hiroki, et al.
Publicado: (2021)

Secondary disseminated intraperitoneal hydatid cyst: A case report
por: Paloyo, Siegfredo R., et al.
Publicado: (2022)

Properties of $^{211}_{85}$At$_{126}$ as observed in the decay of $^{211}$Rn
por: Astner, G
Publicado: (1972)

Radioimmunotherapy with an (211)At‐labeled anti–tissue factor antibody protected by sodium ascorbate
por: Takashima, Hiroki, et al.
Publicado: (2021)

Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment
por: Baldwin, Paige, et al.
Publicado: (2018)

Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
por: Sakamoto, Shuichi, et al.
Publicado: (2019)

Intraperitoneal administration of nanoparticles containing tocopheryl succinate prevents peritoneal dissemination
por: Hama, Susumu, et al.
Publicado: (2022)

Site-specific implantation in the milky spots of malignant cells in peritoneal dissemination: immunohistochemical observation in mice inoculated intraperitoneally with bromodeoxyuridine-labelled cells.
por: Tsujimoto, H., et al.
Publicado: (1995)

Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011)

Tumor Targeting of (211)At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
por: Takashima, Hiroki, et al.
Publicado: (2022)

Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice
por: Ukon, Naoyuki, et al.
Publicado: (2020)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

Effect of Intraperitoneal (224)Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2023)

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.
por: Larsen, R. H., et al.
Publicado: (1994)

Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.
por: Hauck, M. L., et al.
Publicado: (1998)

Evidence of Local Concentration of α-Particles from (211)At-Labeled Antibodies in Liver Metastasis Tissue
por: Kodaira, Satoshi, et al.
Publicado: (2019)

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
por: Huang, Xuhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpmksbetrij7cgtfrhfla8kf43